Neonatal Health & AI Explainability
Revolutionizing Neonatal Risk Prediction with Interpretable AI
This research introduces AIMEN, an Artificial Intelligence framework designed to enhance early detection of intrapartum risks and provide actionable insights for clinical decision-making. By employing advanced data augmentation and counterfactual explanations, AIMEN addresses the critical need for accurate, interpretable risk assessments in neonatal health.
Key Outcomes & Strategic Advantages
AIMEN delivers quantifiable improvements in predictive accuracy and clinical interpretability, offering a robust solution for complex neonatal health challenges.
0.784
Average F1 Score
0.778
CP Prediction Accuracy
2.5
Avg. Counterfactual Sparsity
0.33
Avg. Counterfactual Distance
Deep Analysis & Enterprise Applications
Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.
AIMEN System Overview
AIMEN's design comprises a data generator, a risk predictor, and an explainer, enabling robust learning from challenging datasets and providing actionable insights for neonatal health. This modular framework allows for continuous improvement and adaptability in clinical settings.
Enterprise Process Flow
Data Generator
→
Augmented Training Data
→
Risk Predictor
→
Risk Explainer
Optimized Data Augmentation Strategy
CTGAN proved superior to ADASYN for data augmentation, enhancing model accuracy. While restricted R-AIMEN improved validation loss, unrestricted CTGAN maintained better test set performance by preserving natural data distribution, crucial for real-world reliability.
| Feature | AIMEN (Unrestricted CTGAN) | ADASYN | R-AIMEN (Restricted CTGAN) |
|---|---|---|---|
| Test Set Accuracy |
|
|
|
| Distribution Gap |
|
|
|
| Clinical Realism |
|
|
|
Actionable Counterfactual Explanations
AIMEN generates counterfactual explanations, identifying 2-3 minimal changes (e.g., FHR patterns, fetal weight) required to shift an abnormal prediction to normal. This provides clinicians with actionable what-if scenarios, such as reducing abnormal heart rate and fetal weight to mitigate risks.
Case Study: Counterfactual Explanations for Neonatal Risk
Key Takeaway: AIMEN's counterfactual explanations offer specific, minimal changes to risk factors that could prevent adverse neonatal outcomes, providing invaluable 'what-if' insights for clinicians.
For a specific abnormal labor case, AIMEN can suggest actionable interventions. For instance, modifying the absence of fetal heart rate acceleration (ABSENTACCELTOTAL) from a high value to a lower one, or adjusting abnormal decelerations (ABNDECELTOTAL), can flip the prediction from abnormal to normal. These scenarios, requiring an average of 2.5 attribute changes, highlight the most impactful factors for risk mitigation, such as managing fetal heart rate dynamics, controlling fetal weight, or optimizing labor duration.
Superior Predictive Performance
AIMEN achieved an average F1 score of 0.784, outperforming baselines like XGBoost and LightGBM. It excels in predicting Cerebral Palsy (0.778 accuracy, 0.880 AUROC) but shows lower sensitivity for short-term indicators like Apgar score.
0.784
Overall Macro Average F1 Score
| Model | Average Accuracy | Average F1 Score |
|---|---|---|
| AIMEN (MLP_v5) | 0.753 ± 0.044 | 0.737 ± 0.050 |
| XGBoost | 0.742 ± 0.043 | 0.726 ± 0.051 |
| LightGBM | 0.726 ± 0.076 | 0.700 ± 0.097 |
| TabNet | 0.532 ± 0.043 | 0.430 ± 0.091 |
| DANETS | 0.695 ± 0.063 | 0.666 ± 0.082 |
Calculate Your Potential AI Impact
Estimate the efficiency gains and cost savings AI can bring to your operations in Neonatal Health.
Estimated Annual Savings
Total Hours Reclaimed Annually
Your AI Implementation Roadmap
A structured approach to integrating AIMEN into your clinical workflow, from initial assessment to full-scale deployment and continuous optimization.
Phase 1: Discovery & Strategy
Duration: 2-4 Weeks
Comprehensive assessment of current neonatal monitoring practices, data infrastructure, and clinical goals. Define key performance indicators (KPIs) and tailor AIMEN's integration strategy to align with existing systems and desired outcomes.
Phase 2: Pilot & Refinement
Duration: 8-12 Weeks
Deploy AIMEN in a controlled pilot environment, focusing on specific clinical units. Collect feedback, validate predictions against real-world cases, and refine the model parameters and counterfactual explanation logic for optimal performance and user adoption.
Phase 3: Full-Scale Deployment & Optimization
Duration: Ongoing
Roll out AIMEN across all relevant departments. Establish continuous monitoring, performance tracking, and regular updates to the AI model using new data. Provide ongoing training and support to clinical staff, ensuring maximum value and sustained improvement in neonatal care.
Ready to Transform Neonatal Care?
Schedule a personalized consultation with our AI experts to explore how AIMEN can be tailored for your institution.
Ready to Get Started?
Book Your Free Consultation.
Let's Discuss Your AI Strategy!
Lets Discuss Your Needs
Select a Date
Sun
Mon
Tue
Wed
Thu
Fri
Sat